Abstract:Gene therapeutics is a rapidly developing field promising critical advances in finding new vaccines and treatments, as well as genetic adjustments to plants and animal species. This novel area of science may generate treatment pathways for complex diseases such as cancer, Alzheimer's or sickle cell anemia that can not be easily treated by conventional therapies. Recently developed CRISPR technology can help address these issues, having a power to perform treatment targeted to specific disease mechanisms with little to no adverse effects to the healthy tissue. Many gene therapies require intracellular delivery, and their efficacy can be highly influenced by the choice of the delivery vehicle. Due to their near-infrared fluorescence capabilities and large payload carrying capacity, carbon nanomaterials can be appropriate candidates for this role. Our work utilizes graphene quantum dots (GQDs) and single-walled carbon nanotubes (SWCNTs) as delivery vehicles for several CRISPR-Cas9-based formulations specifically designed to edit out genes related to immortalization and uncontrolled growth of cancer cells. Both of these nanomaterials exhibit visible and near-infrared fluorescence capabilities sufficient for in vitro and in vivo imaging, and, when bound to CRISPR-Cas9 system, are not only expected to transport the therapeutic, but also trace its delivery pathways. In order to warrant more efficient complexation with CRISPR-Cas9 system, GQDs are synthesized bottom-up from cationic polymers and characterized to exhibit stable fluorescence and high biocompatibility at ~1 mg/mL in vitro. Payload attachment is assessed microscopically and reflected by Zeta potential variation upon complexation. Both resulting nanomaterials-delivered formulations show successful target gene scission and intracellular tracking of the gene therapeutic via intrinsic nanomaterial fluorescence. The end goal of this work is to edit out and/or correct aberrant genes in cancer cells making them more susceptible to conventional treatment pathways, thus, ultimately helping improve cancer survival rates.

(Invited) CRISPR-Cas9-Based Cancer Therapy Delivery By Carbon Nanomaterials

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment

Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment

Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy

Strategies for organic nanoparticles delivering CRISPR/Cas9 for cancer therapy: Challenges and breakthroughs

In Vitro Prostate Cancer Treatment via CRISPR-Cas9 Gene Editing Facilitated by Polyethyleneimine-Derived Graphene Quantum Dots

Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid Via a Gold Nanocluster/Lipid Core-Shell Nanocarrier

Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy

A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy

Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment

Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy

Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy Via Liposome-Templated Hydrogel Nanoparticles

Crispr / Cas9 System And Its Application In Tumor Therapy

CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery

Effective Genome Editing Using CRISPR-Cas9 Nanoflowers

CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy

Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management

GFP Plasmid and Chemoreagent Conjugated with Graphene Quantum Dots as a Novel Gene Delivery Platform for Colon Cancer Inhibition In Vitro and In Vivo

Quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy

Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy

A cancer cell membrane‐derived biomimetic nanocarrier for synergistic photothermal/gene therapy by efficient delivery of CRISPR/Cas9 and gold nanorods